Dawit Aregawi

Dawit Aregawi is an Assistant Professor in the Department of Neurosurgery at Penn State Cancer Institute and Penn State Neuroscience Institute. His research focuses on neuro-oncology, particularly glioblastoma and triple-negative breast cancer, with expertise in chemotherapy, biomarker discovery, and tumor microenvironment dynamics.

• Key research areas: Glioblastoma, Ferroptosis, Biomarker Discovery, Triple-Negative Breast Cancer, Cancer Stem Cells, Medical Therapy

The recent articles highlight his work on:

• Tumor cell death mechanisms via neutrophil phagocytosis (2024)
• CSF biomarker standardization for clinical oncology (2024)
• Overcoming drug resistance in breast cancer through kinase inhibition (2024)
• Personalized chemotherapy for recurrent glioblastoma (2023)

His work contributes to UN Sustainable Development Goals related to health equity and cancer care innovation.